Regeneron Pharmaceuticals has won Food and Drug Administration approval of extended dosing intervals of up to every 20 weeks for its Eylea HD eye drug.

Shares of Biogen BIIB rose 2% on Monday after the company announced that the FDA approved a higher dose of its blockbuster ...

On March 30, 2026, the FDA approved a high dose regimen for Spinraza (nusinersen) for the treatment of spinal muscular atrophy.

Please provide your email address to receive an email when new articles are posted on . In February, the CDC released provisional guidance for the use of pretomanid as part of the bedaquiline, ...

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

March 30 (Reuters) - The U.S. Food and Drug Administration has approved a higher-dose version of Biogen's drug for a rare ...

Mayzent (siponimod) is a prescription drug used to treat certain forms of multiple sclerosis (MS). The drug comes as an oral tablet that’s typically taken once per day. Mayzent is used in adults to ...

Celebrex contains the active ingredient celecoxib. It belongs to a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). This drug comes as a capsule that you swallow. The dose of ...

In collaboration with researchers in South Korea, a team from The Hospital for Sick Children (SickKids) has discovered a ...

Trexall (methotrexate) is a brand-name oral tablet. It’s prescribed for certain kinds of cancer, arthritis, and psoriasis in adults and some children. The dosage varies depending on the condition ...

Xifaxan (rifaximin) is a brand-name drug prescribed for irritable bowel syndrome with diarrhea (IBS-D), traveler’s diarrhea, and hepatic encephalopathy (HE). The drug’s dosage varies depending on a ...